Pharmacokinetics and Biotransformation

Correct Answer

C — Chloroquine

Rationale

Chloroquine is classified as having one of the highest volumes of distribution of any clinical drug, estimated at several hundred liters per kilogram in some references, reflecting massive sequestration in tissues including liver, spleen, kidney, and melanin-containing cells. Gentamicin is hydrophilic and has a low volume of distribution, remaining largely in extracellular fluid. Warfarin is highly protein-bound in plasma and has a relatively low volume of distribution. Lithium distributes into total body water and has a modest volume of distribution.

Correct Answer

A — Warfarin

Rationale

Warfarin is classified as highly albumin-bound, with approximately 99 percent of the drug in plasma bound to albumin. This high degree of protein binding is a defining pharmacokinetic characteristic of warfarin and is the basis for clinically important displacement interactions. Lithium is not protein-bound and distributes freely in body water. Aminophylline has moderate protein binding. Metformin has negligible plasma protein binding.

Correct Answer

D — Lithium

Rationale

Lithium is classified as having a low volume of distribution of approximately 0.6 to 1.0 liters per kilogram, consistent with distribution throughout total body water without significant accumulation in adipose or other tissue compartments. This property makes lithium relatively amenable to removal by hemodialysis in overdose. Amiodarone and chloroquine have extremely high volumes of distribution due to extensive tissue binding. Digoxin also has a large volume of distribution, distributing widely into skeletal and cardiac muscle.

Correct Answer

B — Propranolol

Rationale

Propranolol is classified as a highly lipophilic beta-blocker with a large volume of distribution, enabling extensive tissue penetration including the central nervous system. This property accounts for central nervous system side effects such as vivid dreams, depression, and fatigue that are more common with propranolol than with hydrophilic beta-blockers. Atenolol, nadolol, and sotalol are hydrophilic beta-blockers with low volumes of distribution, limited central nervous system penetration, and primarily renal elimination.

Correct Answer

C — Phenytoin

Rationale

Phenytoin is classified as highly albumin-bound, with approximately 90 percent of the drug in plasma bound to albumin. When albumin is reduced, a greater fraction of the total measured phenytoin exists as free (active) drug. A patient with low albumin may have a total phenytoin level within the reference range but a toxic free level, or alternatively appear subtherapeutic by total level while the free level is adequate. Free phenytoin monitoring or application of a correction formula is the standard approach in hypoalbuminemia and renal failure. Levetiracetam and gabapentin have negligible plasma protein binding; topiramate has low to moderate binding.

Correct Answer

A — Aminoglycosides

Rationale

Aminoglycosides (gentamicin, tobramycin, amikacin) are classified as hydrophilic drugs with a low volume of distribution of approximately 0.25 liters per kilogram, reflecting distribution primarily in extracellular fluid with minimal intracellular or tissue penetration. This property is the pharmacokinetic basis for dosing aminoglycosides by lean body weight in obese patients, and for their limited penetration into abscesses and intracellular compartments. Macrolides, fluoroquinolones, and tetracyclines are lipophilic antibiotics with large volumes of distribution and good intracellular penetration.

Correct Answer

D — The drug distributes extensively into tissues, leaving a small fraction in plasma

Rationale

Volume of distribution is a mathematical construct — the hypothetical volume that would be required to contain all of the drug in the body at the same concentration measured in plasma. A value of 500 liters far exceeds total body water (approximately 42 liters in a 70-kilogram adult), which is physically impossible as a real fluid volume. This tells us that the measured plasma concentration is very low relative to the total amount of drug in the body, meaning most of the drug has left the plasma and accumulated in tissues. A high volume of distribution reflects lipophilicity and tissue binding, not literal fluid volume. Drugs with low volumes of distribution (near plasma volume of about 3 to 5 liters) remain largely in plasma.

Correct Answer

B — Acidic drugs bind albumin; basic drugs bind alpha-1-acid glycoprotein

Rationale

Albumin is the primary plasma binding protein for acidic drugs — including warfarin, phenytoin, furosemide, nonsteroidal anti-inflammatory drugs, and many penicillins. Alpha-1-acid glycoprotein (also called orosomucoid) is the primary binding protein for basic drugs including lidocaine, propranolol, tricyclic antidepressants, and many opioids. This distinction matters clinically because conditions that reduce albumin (liver disease, nephrotic syndrome, malnutrition) primarily affect acidic drug binding, while conditions that increase alpha-1-acid glycoprotein (acute phase response, myocardial infarction, surgery) can reduce the free fraction of basic drugs and potentially diminish their effect at the same total concentration.

Correct Answer

C — High lipophilicity and un-ionized form at physiological pH

Rationale

The blood-brain barrier consists of brain capillary endothelial cells joined by tight junctions, with minimal pinocytosis and no fenestrations. Passive diffusion across this barrier requires that the drug be lipophilic enough to partition into the lipid bilayer of the endothelial cell membrane, and un-ionized enough at physiological pH to be membrane-permeant. Drugs that are highly ionized at pH 7.4, highly water-soluble, or large polar molecules are largely excluded from the central nervous system by passive diffusion. High plasma protein binding also limits blood-brain barrier penetration because only free unbound drug is available for diffusion. This is why fentanyl (lipophilic, un-ionized) penetrates the central nervous system rapidly while morphine (less lipophilic) is slower to enter.

Correct Answer

A — Volume of distribution

Rationale

The loading dose is calculated as the target plasma concentration multiplied by the volume of distribution. Volume of distribution determines how much drug the body must contain to achieve a given plasma concentration — a drug with a large volume of distribution requires a larger loading dose to fill the tissue compartments and produce the desired plasma level. Clearance determines the maintenance dose required to sustain steady state, not the loading dose. Half-life determines how long it takes to reach steady state without a loading dose, but does not directly set the loading dose size. Bioavailability affects the oral loading dose calculation but does not determine the size of the loading dose itself.

Correct Answer

D — Reduced albumin increases the free fraction of phenytoin, so the free drug concentration may be therapeutic despite a low total level

Rationale

Phenytoin is approximately 90 percent albumin-bound in patients with normal albumin. When albumin falls, fewer binding sites are available and a higher fraction of the total drug remains free in plasma. The free (unbound) drug is the pharmacologically active fraction that crosses the blood-brain barrier and produces the antiepileptic effect. In a patient with low albumin, a total phenytoin level that appears subtherapeutic by standard reference ranges may represent a fully therapeutic free level. Clinically, this is managed by measuring free phenytoin levels directly, or by applying a correction formula that adjusts the measured total level for the patient's albumin concentration.

Correct Answer

B — The free warfarin concentration rises transiently as displacement increases the unbound fraction

Rationale

When a second drug displaces warfarin from albumin binding sites, the immediate effect is an increase in the free (unbound) warfarin fraction and a transient rise in free drug concentration. This transiently increases anticoagulant effect and bleeding risk. However, the increase in free drug also increases its availability for hepatic metabolism and renal elimination, so clearance of free drug rises as well. For most displacement interactions, the net long-term effect on free steady-state concentration is smaller than the initial transient effect because clearance compensates. The total plasma warfarin level may actually fall because more free drug is being cleared. The clinical concern is the transient peak in free drug during the initial period before a new equilibrium is established.

Correct Answer

C — The expanded extracellular fluid volume increases the volume of distribution of gentamicin, requiring more drug to achieve the target concentration

Rationale

Gentamicin is a hydrophilic aminoglycoside that distributes primarily in extracellular fluid. Edema represents an expansion of the extracellular fluid compartment — the same space into which gentamicin distributes. When this compartment is enlarged by edema or ascites, the volume of distribution of hydrophilic drugs increases proportionally. Since loading dose equals target concentration multiplied by volume of distribution, a larger volume requires a larger loading dose to achieve the same target plasma concentration. This is why gentamicin loading doses are based on actual body weight in edematous patients rather than adjusted body weight, and why standard weight-based loading doses may be inadequate in patients with significant third-spacing of fluid.

Correct Answer

A — The initial rapid decline reflects distribution of drug from plasma into peripheral tissues; the slower decline reflects elimination

Rationale

Drugs that behave according to a two-compartment pharmacokinetic model show a biphasic concentration-time curve after an intravenous bolus. The first phase — called the alpha or distribution phase — reflects rapid movement of drug from the central compartment (plasma and highly perfused organs) into the peripheral compartment (muscle, adipose, and other tissues). Plasma concentrations fall steeply during this phase not because drug is being eliminated, but because it is leaving the plasma. The second phase — called the beta or elimination phase — begins when distribution equilibrium is achieved between compartments, and plasma concentrations then fall more slowly as drug is cleared by metabolism and excretion. This distinction is clinically important: a drug level drawn during the distribution phase will dramatically overestimate the eventual equilibrium concentration, which is why post-bolus drug levels must be timed correctly.

Correct Answer

D — Low albumin increases the free fraction of phenytoin, so a total level of 7 may represent a therapeutic or even toxic free level

Rationale

The standard phenytoin therapeutic range of 10 to 20 micrograms per milliliter was established in patients with normal albumin. When albumin is low, the free fraction of phenytoin rises above the usual 10 percent. A patient with albumin of 2.0 grams per deciliter may have a free phenytoin fraction of 20 to 25 percent, meaning a total level of 7 micrograms per milliliter could correspond to a free level that is fully therapeutic or even supratherapeutic. Increasing the dose based solely on the low total level risks causing phenytoin toxicity. The correct approach is to measure a free phenytoin level or apply the Sheiner-Tozer correction formula to estimate the equivalent total level at normal albumin before making any dose adjustment.

Correct Answer

B — The expanded extracellular fluid volume from edema increases the volume of distribution, diluting the drug below target concentration

Rationale

Gentamicin distributes primarily in extracellular fluid. Edema represents an expansion of the extracellular fluid compartment, which is the same compartment into which gentamicin distributes. When the volume of distribution is enlarged by edematous fluid, the same loading dose is diluted across a larger space, resulting in a lower peak plasma concentration than expected. The fix is to increase the loading dose in proportion to the expanded volume — in practice, using the patient's actual body weight including the edema fluid — rather than lean body weight. Gentamicin is not metabolized hepatically and has negligible protein binding, making those options pharmacokinetically implausible.

Correct Answer

C — Low volume of distribution and low plasma protein binding

Rationale

Hemodialysis removes drug by filtering plasma across a semipermeable membrane. For dialysis to be effective, drug must be present in plasma in meaningful concentrations — which requires a low volume of distribution. A drug with a large volume of distribution has most of its total body burden sequestered in tissues, with very little in plasma; removing plasma drug by dialysis barely dents the total drug load because tissue drug rapidly re-equilibrates back into plasma. Low protein binding is also required because only free (unbound) drug crosses the dialysis membrane. Lithium exemplifies a dialyzable drug: low volume of distribution, no protein binding, and water solubility. Digoxin and tricyclic antidepressants have large volumes of distribution and are not effectively removed by dialysis. Hepatic metabolism and biliary elimination are not relevant to dialyzability.

Correct Answer

A — The fall in albumin increased the free fraction of warfarin, producing greater anticoagulant effect at the same total plasma level

Rationale

Warfarin is approximately 99 percent albumin-bound. When albumin falls during critical illness, the free fraction of warfarin rises substantially — even a small change in bound fraction produces a large proportional increase in free drug. The free warfarin exerts the anticoagulant effect by inhibiting vitamin K epoxide reductase and reducing synthesis of clotting factors. At the same total warfarin dose, a patient with low albumin may have double or triple the free warfarin concentration of a patient with normal albumin, explaining the markedly elevated international normalized ratio. Managing warfarin in intensive care unit patients with dynamic albumin levels requires frequent monitoring and dose reduction when albumin falls.